Explore January 2025's liquidity surplus, potential $1.1T tax cuts, paused Fed hikes, and rising risk asset opportunities for ...

CGI's stock appears fully valued despite cost reduction efforts and strong FCF, with limited upside absent revenue growth.

Evercore ISI boosted their target price on Blue Owl Capital from $25.00 to $26.00 and gave the company an “outperform” rating in a research report on Friday, January 17th.

Rosenblatt Securities analyst Blair Abernethy maintained a Buy rating on PDF Solutions (PDFS – Research Report) today and set a price target of ...

In a report released today, Jason Gerberry from Bank of America Securities reiterated a Sell rating on Organon (OGN – Research Report). The ...

JMP Securities maintained a positive outlook on Blue Owl Capital (NYSE: OWL) shares, reiterating a Market Outperform rating with a steady price target of $32.00. The firm's analysis highlighted Blue ...

The first drilling program by Kincora with earn-in partner AngloGold Ashanti Australia Limited (AngloGold Ashanti) at the ...

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

Southern California institutions could lose out on hundreds of millions of dollars in funding if the Trump administration‘s proposed cuts to overhead for biomedical research move forward.

We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not ...